4/A//SEC Filing
Lebovits Chaim 4/A
Accession 0001104659-24-084337
CIK 0001137883other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:06 PM ET
Size
6.9 KB
Accession
0001104659-24-084337
Insider Transaction Report
Form 4/AAmended
Lebovits Chaim
President & CEO
Transactions
- Purchase
Common Stock
2024-05-06$0.38/sh+135,000$50,666→ 993,565 total
Holdings
- 2,000,847(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]On May 7, 2024, the Reporting Person filed a Form 4 which inadvertently included the incorrect transaction code due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
- [F2]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.3498 to $0.399, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001406302
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:06 PM ET
- Size
- 6.9 KB